Hedge Fund and Insider Trading News: Bill Ackman, Mike Novogratz, Sanjay Shah, LIOR Global Partners, Anomaly Capital, Two Sigma Investments, Intercept Pharmaceuticals Inc (ICPT), Kaiser Aluminum Corp. (KALU), and More
Billionaire investor Bill Ackman said Monday he donated his entire stake in Coupang – worth more than $1 billion – to charity following the South Korean e-commerce company’s IPO last week. Ackman, who runs the
Pershing Square Capital Management hedge fund, invested his personal money as an early backer of Coupang, CNBC first reported last Thursday on the firm’s NYSE debut.
Two Sigma Investments plans to ask staff to return to the office in September and will experiment with a hybrid model that allows them to work remotely two days a week. Employees should expect the change to take effect after Labor Day, “but that’s going to depend on the science, the availability of vaccines, and schools opening, global regulations,” Two Sigma Chief Technology Officer
Norway s Fourth-Richest Man Invests in a Crypto Mining ASIC Manufacturer
According to regional reports, the Norwegian billionaire and hedge fund manager, Ole Andreas Halvorsen, is investing funds into an energy-reducing cryptocurrency mining chip hardware company. The company Norway’s fourth richest man is investing in claims to build application-specific integrated circuit (ASIC) mining chips that are allegedly 300%-500% more energy efficient than existing hardware.
Norwegian Hedge Fund Giant Dips Into the Crypto Economy
Swedish news site Trijo reports that the billionaire hedge fund manager Ole Andreas Halvorsen is dipping his toes into the cryptocurrency space. A report from Trijo explains that the hedge fund manager and cofounder of the Connecticut-based hedge fund, Viking Global Investors, is now investing in a cryptocurrency-focused firm called Harmonychain.
Amunix Pharmaceuticals raises $117 million to pivot to cancer drugs - San Francisco Business Times bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
(Lia Shaked)
Health technology company Carevive which developed a platform that helps clinicians create personalized treatment plans for cancer patients won a new major backer last month.
The company banked a series C equity investment of $18 million with support from Philips Health Technology Ventures. Phillips joined prior investors HLM Venture Partners, LRVHealth, Cerner and founder Madelyn Trupkin Herzfeld in the round.
Carevive s platform allows clinicians to tailor cancer care management programs for each patient s needs, informed by real-world patient experiences and outcomes, not just clinical data. Its remote symptom management system means patients need to take fewer trips to health centers. And Carevive s data and analytics are helping researchers design innovative cancer care delivery models, payers to reimburse treatments effectively and life science companies to develop personalized therapies for cancer.
Your article was successfully shared with the contacts you provided.
A boutique firm may seem an unlikely venture for Gregory Fleming to helm. After all, he spent virtually his whole career at two wirehouses Morgan Stanley and Merrill Lynch, where he topped out as president of wealth and asset management, and president, respectively.
But a smaller enterprise with an entrepreneurial mindset is exactly what Fleming, 57, is now running. The investment banker who helped Bank of America buy Merrill’s business and helped former Yankee Derek Jeter in the consortium acquisition of the Miami Marlins is relishing the job of recasting the Rockefeller family office into a wealth management firm, as he tells ThinkAdvisor in an interview.